All diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients who are 20 years old or more at the time of consent acquisition. (2) Patients provided written informed consent (3)Patients who have been issued prescriptions by medical institutions
Exclusion criteria
Exclusion criteria: (1)Requested for cancellation from patients (2)Interrupted due to the circumstances of the research patients (moving, changing doctor / hospital, busy, unfollowable) (3)Judged that evaluation is not possible due to serious deviation from protocol (4)Patients judged inappropriate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An observation period of 6 months or more will be provided from the start of registration. Health-related QOL is measured 4 or more times during the observation period. The primary endpoint is quality-adjusted life years (QALY). | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event | — |
Countries
Japan
Contacts
Qol Co., Ltd. Kanto Pharmacy Headquarter 1